Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Circulate Capital is a Singapore-based investment management firm dedicated to advancing the circular economy and combating plastic pollution, primarily in South and Southeast Asia. Founded in 2018, the firm manages several impact-focused funds, including the Circulate Capital Ocean Fund and Circulate Capital Disrupt, which invest in recycling infrastructure, waste management supply chains, and disruptive climate technologies. The firm is backed by a coalition of major multinational corporations such as PepsiCo, Procter & Gamble, Dow, and Danone. In early 2026, Circulate Capital announced the first close of its second Asia-focused fund at $220 million to scale circular supply chains and material recovery across high-growth markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Circulate Capital.